ARNI (Arno Therapeutics) Beginning Cash Position: $0.94 Mil (As of Sep. 2016)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Arno Therapeutics Beginning Cash Position?

Arno Therapeutics ARNI Beginning Cash Position is $0.94 Mil as of Sep. 2016.

Arno Therapeutics's Beginning Cash Position for the quarter that ended in Sep. 2016 was $0.94 Mil.

Arno Therapeutics's quarterly Beginning Cash Position increased from Mar. 2016 ($0.07 Mil) to Jun. 2016 ($2.68 Mil) but then declined from Jun. 2016 ($2.68 Mil) to Sep. 2016 ($0.94 Mil).

Arno Therapeutics's annual Beginning Cash Position increased from Dec. 2013 ($10.94 Mil) to Dec. 2014 ($26.77 Mil) but then declined from Dec. 2014 ($26.77 Mil) to Dec. 2015 ($7.95 Mil).

Arno Therapeutics Beginning Cash Position Related Terms

Arno Therapeutics Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Arno Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arno Therapeutics Beginning Cash Position Chart

Arno Therapeutics Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.53 6.68 10.94 26.77 7.95

Arno Therapeutics Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.37 0.12 0.07 2.68 0.94

Arno Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.94 Mil mean?
Arno Therapeutics (ARNI) has a Beginning Cash Position of $0.94 Mil as of Sep. 2016. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Arno Therapeutics and its competitors.
Is Arno Therapeutics' Beginning Cash Position too high?
Arno Therapeutics' current Beginning Cash Position is $0.94 Mil.
How does Arno Therapeutics' Beginning Cash Position compare to PLPL and BTHE?
Arno Therapeutics' Beginning Cash Position of $0.94 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Arno Therapeutics and its competitors. Arno Therapeutics's current Beginning Cash Position is $0.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arno Therapeutics stock overvalued right now?
Arno Therapeutics (ARNI) has a current Beginning Cash Position of $0.94 Mil. The current Beginning Cash Position is $0.94 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Arno Therapeutics (ARNI), the current Beginning Cash Position is $0.94 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arno Therapeutics Business Description

Address 200 Route 31 North, Suite 104, Flemington, NJ, USA, 08822
Arno Therapeutics Inc operates as a biopharmaceutical company. It develops drug candidates to treat patients with cancer and other life-threatening diseases. It develops pre-clinical and clinical-stage product under the following name: Onapristone, AR-42, and AR-12. Onapristone is indicated for endometrial, prostate and breast cancer indications, AR-42 is provided for hematological malignancies and solid tumors indications and AR-12 is offered for solid tumors and hematological malignancies, and various anti-microbial targets.